Cargando…
Oncogenic kinase fusions: an evolving arena with innovative clinical opportunities
Cancer biology relies on intrinsic and extrinsic deregulated pathways, involving a plethora of intra-cellular and extra-cellular components. Tyrosine kinases are frequently deregulated genes, whose aberrant expression is often caused by major cytogenetic events (e.g. chromosomal translocations). The...
Autores principales: | Tabbò, Fabrizio, Pizzi, Marco, Kyriakides, Peter W., Ruggeri, Bruce, Inghirami, Giorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041889/ https://www.ncbi.nlm.nih.gov/pubmed/26943776 http://dx.doi.org/10.18632/oncotarget.7853 |
Ejemplares similares
-
ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma
por: Tabbó, Fabrizio, et al.
Publicado: (2012) -
A European arena for joint innovation in healthcare: The Platform for Innovation of Procurement and Procurement of Innovation (PiPPi)
por: Andrews, Margaret R., et al.
Publicado: (2023) -
The Arena
Publicado: (1894) -
Resistance to anaplastic lymphoma kinase inhibitors: knowing the enemy is half the battle won
por: Tabbò, Fabrizio, et al.
Publicado: (2020) -
Editorial: Concomitant pathogenic mutations in oncogene-driven subgroups: when next generation biology meets targeted therapy in NSCLC
por: Malapelle, Umberto, et al.
Publicado: (2023)